Search

Search Results
Results 8251 - 8260 of 8357 for allergy
  • QTERN
    Drug - 19 Sep 2022
    Consumer Medicine Information (CMI) about QTERN intended for persons living in Australia.
  • Forxiga
    Drug - 9 Sep 2022
    Consumer Medicine Information (CMI) about Forxiga intended for persons living in Australia.
  • Endep
    Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Endep intended for persons living in Australia.
  • Dothep
    Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Dothep intended for persons living in Australia.
  • Dosulepin Viatris (formerly Dosulepin Mylan)
    Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Dosulepin Viatris (formerly Dosulepin Mylan) intended for persons living in Australia.
  • Amitriptyline Viatris (formerly Amitriptyline Alphapharm)
    Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Amitriptyline Viatris (formerly Amitriptyline Alphapharm) intended for persons living in Australia.
  • Tenofovir Disoproxil Emtricitabine Viatris
    Drug - 2 Sep 2022
    Consumer Medicine Information (CMI) about Tenofovir Disoproxil Emtricitabine Viatris (300 mg tenofovir disoproxil maleate/200 mg emtricitabine) intended for persons living in Australia.
  • Toradol Tablets
    Drug - 29 Aug 2022
    Consumer Medicine Information (CMI) about Toradol Tablets intended for persons living in Australia.
  • Blincyto
    Drug - 29 Aug 2022
    Consumer Medicine Information (CMI) about Blincyto intended for persons living in Australia.
  • Breztri Aerosphere
    Drug - 17 Aug 2022
    Consumer Medicine Information (CMI) about Breztri Aerosphere intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback